{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:11:31Z","timestamp":1789143091058,"version":"build-2803163510"},"reference-count":70,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiomyopathies are increasingly managed with disease-modifying and phenotype-specific therapies, creating a need for imaging biomarkers that can reliably capture treatment response over time. Cardiovascular magnetic resonance (CMR) is uniquely suited to this role because it combines highly reproducible assessment of cardiac structure and function with detailed tissue characterization. Cine imaging enables serial evaluation of ventricular volumes, mass, and ejection fraction; late gadolinium enhancement identifies focal replacement fibrosis and arrhythmogenic substrate; and native T1\/T2 mapping with extracellular volume quantification provides quantitative markers of diffuse fibrosis, oedema, inflammation, and infiltrative burden. In this review, we discuss the role of CMR in therapy monitoring across the spectrum of cardiomyopathies. In dilated cardiomyopathy, CMR tracks reverse remodelling and helps identify persistent scar and non-response despite guideline-directed therapy or cardiac resynchronization. In non-dilated and arrhythmogenic cardiomyopathies, serial tissue characterization helps refine dynamic arrhythmic risk. In hypertrophic cardiomyopathy, CMR documents structural and interstitial changes during treatment with myosin inhibitors and after septal reduction. In amyloid and metabolic\/storage cardiomyopathies, mapping techniques are particularly useful for demonstrating stabilization or regression of myocardial disease under targeted treatments. Overall, CMR offers a framework for standardized longitudinal follow-up and for the development of biologically meaningful surrogate endpoints in clinical trials. Wider harmonization of acquisition, analysis, and reporting will be essential to fully integrate CMR into individualized therapeutic decision-making.<\/jats:p>","DOI":"10.1093\/ehjimp\/qyag153","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T11:30:45Z","timestamp":1788521445000},"source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular magnetic resonance for therapy monitoring in cardiomyopathies"],"prefix":"10.1093","volume":"4","author":[{"given":"Manuel","family":"Garofalo","sequence":"first","affiliation":[{"name":"Cardiomyopathy Unit, Careggi University Hospital , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9049-5320","authenticated-orcid":false,"given":"Giorgia","family":"Panichella","sequence":"additional","affiliation":[{"name":"Cardiomyopathy Unit, Careggi University Hospital , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4285-9468","authenticated-orcid":false,"given":"Alberto","family":"Clemente","sequence":"additional","affiliation":[{"name":"Radiology Division, Fondazione Toscana Gabriele Monasterio , Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6051-3698","authenticated-orcid":false,"given":"Carmelo","family":"De Gori","sequence":"additional","affiliation":[{"name":"Radiology Division, Fondazione Toscana Gabriele Monasterio , Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-340X","authenticated-orcid":false,"given":"Andrea","family":"Barison","sequence":"additional","affiliation":[{"name":"Interdisciplinary Center for Health Sciences, Scuola Superiore Sant\u2019Anna , Piazza Martiri della Libert\u00e0 33, Pisa 56127 ,","place":["Italy"]},{"name":"Cardiology Division, Fondazione Toscana Gabriele Monasterio , via Moruzzi 1, 56124 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Chianca","sequence":"additional","affiliation":[{"name":"Cardiology Division, University Hospital of Pisa , via Roma 55, 56126 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9129-9519","authenticated-orcid":false,"given":"Alberto","family":"Aimo","sequence":"additional","affiliation":[{"name":"Interdisciplinary Center for Health Sciences, Scuola Superiore Sant\u2019Anna , Piazza Martiri della Libert\u00e0 33, Pisa 56127 ,","place":["Italy"]},{"name":"Cardiology Division, Fondazione Toscana Gabriele Monasterio , via Moruzzi 1, 56124 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3459-026X","authenticated-orcid":false,"given":"Giancarlo","family":"Todiere","sequence":"additional","affiliation":[{"name":"Cardiology Division, Fondazione Toscana Gabriele Monasterio , via Moruzzi 1, 56124 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"2026091111370498900_qyag153-B1","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2026091111370498900_qyag153-B2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10741-022-10235-9","article-title":"Clinical application of CMR in cardiomyopathies: evolving concepts and techniques: a position paper of myocardial and pericardial diseases and cardiac magnetic resonance working groups of Italian society of cardiology","volume":"28","author":"Merlo","year":"2023","journal-title":"Heart Fail Rev"},{"key":"2026091111370498900_qyag153-B3","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.122.014743","article-title":"Cardiovascular magnetic resonance tissue characterization by T1 and T2 mapping: a moving target in need of stable references","volume":"15","author":"Jerosch-Herold","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B4","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1093\/eurheartj\/ehad510","article-title":"Cardiac magnetic resonance biomarkers as surrogate endpoints in cardiovascular trials for myocardial diseases","volume":"44","author":"Benz","year":"2023","journal-title":"Eur Heart J"},{"key":"2026091111370498900_qyag153-B5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacep.2020.07.025","article-title":"Long-term outcomes in patients with a left ejection fraction \u226415% undergoing cardiac resynchronization therapy","volume":"7","author":"Rickard","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2026091111370498900_qyag153-B6","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/01.CIR.100.19.1992","article-title":"Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function","volume":"100","author":"Kim","year":"1999","journal-title":"Circulation"},{"key":"2026091111370498900_qyag153-B7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1161\/CIRCIMAGING.111.963421","article-title":"Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage Index","volume":"4","author":"Dall\u2019Armellina","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B8","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.15420\/ecr\/2016:28:2","article-title":"Role of T1 mapping in inherited cardiomyopathies","volume":"11","author":"Swoboda","year":"2016","journal-title":"Eur Cardiol"},{"key":"2026091111370498900_qyag153-B11","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1148\/radiol.12112721","article-title":"T1 mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy","volume":"265","author":"Sibley","year":"2012","journal-title":"Radiology"},{"key":"2026091111370498900_qyag153-B12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/CIRCIMAGING.111.967836","article-title":"Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping","volume":"5","author":"Thavendiranathan","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B13","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/S0735-1097(24)03450-8","article-title":"T2 mapping on cardiac magnetic resonance as a marker for arrhythmia in hypertrophic cardiomyopathy","volume":"83","author":"McCrohan","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026091111370498900_qyag153-B14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132440","article-title":"Magnetic resonance mapping for the assessment of cardiomyopathies and myocardial disease","volume":"415","author":"Gravina","year":"2024","journal-title":"Int J Cardiol"},{"key":"2026091111370498900_qyag153-B15","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jcmg.2021.07.023","article-title":"T1 mapping and extracellular volume fraction in dilated cardiomyopathy","volume":"15","author":"Li","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B16","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1007\/s00330-020-07650-7","article-title":"Prognostic value of myocardial extracellular volume fraction evaluation based on cardiac magnetic resonance T1 mapping with T1 long and short in hypertrophic cardiomyopathy","volume":"31","author":"Li","year":"2021","journal-title":"Eur Radiol"},{"key":"2026091111370498900_qyag153-B17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41569-024-01074-2","article-title":"Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine","volume":"22","author":"Gigli","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"2026091111370498900_qyag153-B18","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007944","article-title":"Myocardial tissue reverse remodeling after guideline-directed medical therapy in idiopathic dilated cardiomyopathy","volume":"14","author":"Xu","year":"2021","journal-title":"Circ Heart Fail"},{"key":"2026091111370498900_qyag153-B19","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jcmg.2018.03.006","article-title":"The prognostic value of late gadolinium-enhanced cardiac magnetic resonance imaging in nonischemic dilated cardiomyopathy","volume":"11","author":"Becker","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B20","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cardfail.2013.05.009","article-title":"Comparison of perfusion-metabolism mismatch in 99mTc-MIBI and 123I-BMIPP scintigraphy with cardiac magnetic resonance in patients with dilated cardiomyopathy","volume":"19","author":"Yoshida","year":"2013","journal-title":"J Card Fail"},{"key":"2026091111370498900_qyag153-B21","article-title":"Myocardial perfusion imaging with cardiovascular magnetic resonance in nonischemic cardiomyopathies: an in-depth review of techniques and clinical applications","volume":"61","author":"Sharka","year":"2025","journal-title":"Medicina (Mex)"},{"key":"2026091111370498900_qyag153-B22","doi-asserted-by":"crossref","DOI":"10.1161\/circ.148.suppl_1.18159","article-title":"Abstract 18159: cardiac resynchronization therapy response predicted by tissue characterization using cardiac magnetic resonance imaging in non-ischemic dilated cardiomyopathy","volume":"148","author":"Oh","year":"2023","journal-title":"Circulation"},{"key":"2026091111370498900_qyag153-B23","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12206673","article-title":"Cardiovascular magnetic resonance in patients with cardiac electronic devices: evidence from a multicenter study","volume":"12","author":"Barison","year":"2023","journal-title":"J Clin Med"},{"key":"2026091111370498900_qyag153-B24","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12123998","article-title":"Feasibility of CMR imaging during biventricular pacing: comparison with invasive measurement as a pathway towards a novel optimization strategy","volume":"12","author":"Hopman","year":"2023","journal-title":"J Clin Med"},{"key":"2026091111370498900_qyag153-B25","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s10554-022-02679-9","article-title":"Prognostic value of cardiac magnetic resonance derived global longitudinal strain analysis in patients with ischaemic and non-ischaemic dilated cardiomyopathy: a systematic review and meta-analysis","volume":"38","author":"Fong","year":"2022","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B26","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jcmg.2022.01.016","article-title":"Left atrial strain has superior prognostic value to ventricular function and delayed-enhancement in dilated cardiomyopathy","volume":"15","author":"Raafs","year":"2022","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131447","article-title":"Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report","volume":"395","author":"Corrado","year":"2024","journal-title":"Int J Cardiol"},{"key":"2026091111370498900_qyag153-B28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00330-022-08958-2","article-title":"Cardiac magnetic resonance imaging of arrhythmogenic cardiomyopathy: evolving diagnostic perspectives","volume":"33","author":"Cipriani","year":"2022","journal-title":"Eur Radiol"},{"key":"2026091111370498900_qyag153-B29","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2025-003441","article-title":"Cardiac magnetic resonance comparison of non-dilated and dilated cardiomyopathy: imaging features and prognostic predictors in non-dilated left ventricular cardiomyopathy","volume":"12","author":"Zhuang","year":"2025","journal-title":"Open Heart"},{"key":"2026091111370498900_qyag153-B30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133224","article-title":"Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: the role of overlap with arrhythmogenic cardiomyopathy","volume":"431","author":"Gueli","year":"2025","journal-title":"Int J Cardiol"},{"key":"2026091111370498900_qyag153-B31","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/ejhf.3671","article-title":"Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy","volume":"27","author":"Setti","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026091111370498900_qyag153-B32","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/ehjci\/jeaf043","article-title":"CarDiac magnEtic resonance for prophylactic implantable cardioVerter defibrillAtor ThErapy in non-dilated left ventricular cardiomyopathy: a sub-study from the DERIVATE registry","volume":"26","author":"Leo","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/eurheartj\/ehaf477","article-title":"Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score","volume":"47","author":"Peretto","year":"2026","journal-title":"Eur Heart J"},{"key":"2026091111370498900_qyag153-B34","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.jacc.2020.04.023","article-title":"Prognostic value of magnetic resonance phenotype in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"75","author":"Aquaro","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026091111370498900_qyag153-B35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031403","article-title":"Incremental diagnostic value of right ventricular strain analysis in arrhythmogenic right ventricular cardiomyopathy","volume":"13","author":"Dong","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026091111370498900_qyag153-B36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41598-019-57203-2","article-title":"Arrhythmogenic left ventricular cardiomyopathy: a clinical and CMR study","volume":"10","author":"He","year":"2020","journal-title":"Sci Rep"},{"key":"2026091111370498900_qyag153-B37","doi-asserted-by":"crossref","first-page":"i36","DOI":"10.1093\/eurheartjsupp\/suae098","article-title":"Risk stratification in arrhythmogenic cardiomyopathy: scoring or personalized medicine?","volume":"27","author":"Martini","year":"2025","journal-title":"Eur Heart J Suppl"},{"key":"2026091111370498900_qyag153-B38","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jacc.2021.12.002","article-title":"Diagnosis and evaluation of hypertrophic cardiomyopathy","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026091111370498900_qyag153-B39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jacc.2009.05.006","article-title":"Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance","volume":"54","author":"Maron","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026091111370498900_qyag153-B40","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/CIRCULATIONAHA.120.052359","article-title":"Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy: EXPLORER-HCM cardiac magnetic resonance substudy analysis","volume":"143","author":"Saberi","year":"2021","journal-title":"Circulation"},{"key":"2026091111370498900_qyag153-B41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jacc.2006.08.055","article-title":"Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy","volume":"49","author":"Valeti","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026091111370498900_qyag153-B42","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic value of LGE-CMR in HCM","volume":"9","author":"Weng","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B43","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCIMAGING.112.000333","article-title":"T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B44","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines","volume":"149","author":"Ommen","year":"2024","journal-title":"Circulation"},{"key":"2026091111370498900_qyag153-B45","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1001\/jama.2026.5633","article-title":"Predictors of long-term outcomes in hypertrophic cardiomyopathy: the NHLBI HCM registry","volume":"335","author":"Kramer","year":"2026","journal-title":"JAMA"},{"key":"2026091111370498900_qyag153-B46","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026091111370498900_qyag153-B47","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamacardio.2023.2010","article-title":"Tracking treatment response in cardiac light-chain amyloidosis with native T1 mapping","volume":"8","author":"Ioannou","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026091111370498900_qyag153-B48","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026091111370498900_qyag153-B49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00392-022-02035-w","article-title":"Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging","volume":"112","author":"Chamling","year":"2023","journal-title":"Clin Res Cardiol"},{"key":"2026091111370498900_qyag153-B50","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcmg.2020.07.043","article-title":"Reduction in CMR derived extracellular volume with patisiran indicates cardiac amyloid regression","volume":"14","author":"Fontana","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B51","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1056\/NEJMc2304584","article-title":"Antibody-associated reversal of ATTR amyloidosis\u2013related cardiomyopathy","volume":"388","author":"Fontana","year":"2023","journal-title":"N Engl J Med"},{"key":"2026091111370498900_qyag153-B52","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ejhf.3137","article-title":"Myocardial perfusion in cardiac amyloidosis","volume":"26","author":"Chacko","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026091111370498900_qyag153-B53","doi-asserted-by":"crossref","first-page":"650","DOI":"10.21037\/cdt-20-593","article-title":"Narrative review on Morbus Fabry: diagnosis and management of cardiac manifestations","volume":"11","author":"Linhart","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"key":"2026091111370498900_qyag153-B54","article-title":"Cardiovascular magnetic resonance findings in Danon disease: a case series of a family","volume":"10","author":"Liu","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"2026091111370498900_qyag153-B55","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1056\/NEJMoa2412392","article-title":"Phase 1 study of AAV9.LAMP2B gene therapy in Danon disease","volume":"392","author":"Greenberg","year":"2025","journal-title":"N Engl J Med"},{"key":"2026091111370498900_qyag153-B56","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12968-016-0311-9","article-title":"Pattern and prognostic value of cardiac involvement in patients with late-onset Pompe disease: a comprehensive cardiovascular magnetic resonance approach","volume":"18","author":"Boentert","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026091111370498900_qyag153-B57","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12968-015-0174-5","article-title":"4D flow cardiovascular magnetic resonance consensus statement","volume":"17","author":"Dyverfeldt","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026091111370498900_qyag153-B58","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.240181","article-title":"Evaluating the effect of heart rate on T2 balanced steady-state free precession cardiac MRI mapping","volume":"7","author":"Fenski","year":"2025","journal-title":"Radiol Cardiothorac Imaging"},{"key":"2026091111370498900_qyag153-B59","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.121.013745","article-title":"Synthetic extracellular volume in cardiac magnetic resonance without blood sampling: a reliable tool to replace conventional extracellular volume","volume":"15","author":"Chen","year":"2022","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026091111370498900_qyag153-B60","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12247752","article-title":"Cardiac magnetic resonance as risk stratification tool in non-ischemic dilated cardiomyopathy referred for implantable cardioverter defibrillator therapy\u2014state of art and perspectives","volume":"12","author":"Argentiero","year":"2023","journal-title":"J Clin Med"},{"key":"2026091111370498900_qyag153-B61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132618","article-title":"Late gadolinium enhancement and outcome of cardiac resynchronization therapy in non-ischemic cardiomyopathy","volume":"418","author":"Anguera","year":"2025","journal-title":"Int J Cardiol"},{"key":"2026091111370498900_qyag153-B62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131603","article-title":"Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis","volume":"397","author":"Pieroni","year":"2024","journal-title":"Int J Cardiol"},{"key":"2026091111370498900_qyag153-B63","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa2504654","article-title":"Aficamten or metoprolol monotherapy for obstructive hypertrophic cardiomyopathy","volume":"393","author":"Garcia-Pavia","year":"2025","journal-title":"N Engl J Med"},{"key":"2026091111370498900_qyag153-B64","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/jamacardio.2023.3030","article-title":"Effect of mavacamten on Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy: the EXPLORER-CN randomized clinical trial","volume":"8","author":"Tian","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026091111370498900_qyag153-B65","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/ehjdh\/ztaf086","article-title":"Artificial intelligence applications in hypertrophic cardiomyopathy: turns and loopholes","volume":"6","author":"Panichella","year":"2025","journal-title":"Eur Heart J Digit Health"},{"key":"2026091111370498900_qyag153-B66","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3348\/kjr.2022.0496","article-title":"Automated measurement of native T1 and extracellular volume fraction in cardiac magnetic resonance imaging using a commercially available deep learning algorithm","volume":"23","author":"Chang","year":"2022","journal-title":"Korean J Radiol"},{"key":"2026091111370498900_qyag153-B67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.echo.2024.10.001","article-title":"Sustained benefits of mavacamten in patients with obstructive hypertrophic cardiomyopathy: long-term assessment using artificial intelligence\u2013electrocardiogram and echocardiographic data","volume":"38","author":"Suppah","year":"2025","journal-title":"J Am Soc Echocardiogr"},{"key":"2026091111370498900_qyag153-B68","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/CIRCULATIONAHA.121.054432","article-title":"Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium-free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy","volume":"144","author":"Zhang","year":"2021","journal-title":"Circulation"},{"key":"2026091111370498900_qyag153-B69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12968-023-00940-1","article-title":"Magnetic resonance myocardial T1\u03c1 mapping","volume":"25","author":"Bustin","year":"2023","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026091111370498900_qyag153-B70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocmr.2024.101606","article-title":"Diffusion tensor imaging in patients with suspected cardiomyopathies","volume":"27","author":"Wang","year":"2025","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["European Heart Journal - Imaging Methods and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjimp\/advance-article-pdf\/doi\/10.1093\/ehjimp\/qyag153\/70969117\/qyag153.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjimp\/article-pdf\/4\/3\/qyag153\/70969117\/qyag153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjimp\/article-pdf\/4\/3\/qyag153\/70969117\/qyag153.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:37:19Z","timestamp":1789141039000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjimp\/article\/doi\/10.1093\/ehjimp\/qyag153\/8786290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjimp\/qyag153","relation":{},"ISSN":["2755-9637"],"issn-type":[{"value":"2755-9637","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,7,2]]},"article-number":"qyag153"}}